Cotinet A, Goureau O, Hicks D, Thillaye-Goldenberg B, de Kozak Y
Laboratoire d'Immunopathologie de l'Oeil, INSERM U86, Paris, France.
Glia. 1997 May;20(1):59-69.
The primary cause of the inherited retinal dystrophy observed in Royal College of Surgeons (RCS) rats is located in the retinal pigmented epithelium, which is unable to phagocytize photoreceptor outer segments. We have demonstrated here that retinal Müller glial (RMG) cells obtained from RCS dystrophic rats and stimulated in vitro with lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma) accumulated higher levels of tumor necrosis factor (TNF) and inducible nitric oxide synthase (NOS II) mRNA and released in culture supernatants significantly higher amounts of TNF and nitrite compared to cells derived from nondystrophic controls. The TNF and NOS II mRNA expression and TNF and nitrite synthesis induced in RMG cells from both strains by LPS + IFN-gamma was significantly prevented by including transforming growth factor-beta (TGF-beta) in the culture medium. Coincubation of the stimulants with an inhibitor of NOS II, NG-monomethyl-L-arginine (L-NMMA), while inhibiting nitrite synthesis, induced an increase of TNF production in supernatants from RMG cells without increasing TNF mRNA levels. The retinal dystrophy observed in RCS dystrophic rats could result from an abnormal susceptibility of RMG cells form RCS dystrophic rats to produce TNF and NO in response to stimulants. Administration of the immunomodulatory cytokine TGF-beta or inhibitors of NOS II would provide additional research avenues for photoreceptor rescue.
在皇家外科学院(RCS)大鼠中观察到的遗传性视网膜营养不良的主要原因位于视网膜色素上皮,其无法吞噬光感受器外段。我们在此证明,从RCS营养不良大鼠获得并在体外用脂多糖(LPS)和干扰素-γ(IFN-γ)刺激的视网膜Müller神经胶质(RMG)细胞积累了更高水平的肿瘤坏死因子(TNF)和诱导型一氧化氮合酶(NOS II)mRNA,并且与来自非营养不良对照的细胞相比,在培养上清液中释放的TNF和亚硝酸盐量显著更高。通过在培养基中加入转化生长因子-β(TGF-β),可显著抑制LPS + IFN-γ诱导的两种品系RMG细胞中TNF和NOS II mRNA表达以及TNF和亚硝酸盐合成。刺激物与NOS II抑制剂NG-单甲基-L-精氨酸(L-NMMA)共同孵育时,虽然抑制了亚硝酸盐合成,但却诱导RMG细胞上清液中TNF产生增加,而不增加TNF mRNA水平。RCS营养不良大鼠中观察到的视网膜营养不良可能是由于RCS营养不良大鼠的RMG细胞对刺激物产生TNF和NO的异常易感性所致。给予免疫调节细胞因子TGF-β或NOS II抑制剂将为光感受器拯救提供额外的研究途径。